Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
Erdoğan C. J Neurosci Rural Pract. Jan 2013; 4(1): 57-8
Pubmed [11371]
Erdogan MA. Arch Med Sci. Nov 2018; 16(1): 205-211
Pubmed [11042]
Ereshefsky L, Jann MW, Saklad SR, Davis CM, Richard AL, Burch NR. Effects of smoking on fluphenazine clearance in psychiatric inpatients. Biol Psychiatry (1985) 20, 329-32 [928]
Ereshefsky L. Clin Pharmacokinet. Jan 1995; 29 Suppl 1: 10-8; discussion 18-9
Pubmed [4476]
Ergamisol (Levamisole). Product information. Physicians' Desk Reference (2002) 1789-91 [2142]
Ergül B. Helicobacter. Dec 2013; 18(6): 454-8
Pubmed [7668]
Erickson DA. Drug Metab Dispos. Dec 1999; 27(12): 1488-95
Pubmed [7210]
Erickson-Ridout KK. Pharmacogenet Genomics. Aug 2012; 22(8): 561-76
Pubmed , Volltext , DOI [9826]
Ericsson CD. JAMA. Apr 1982; 247(16): 2266-7
Pubmed [5622]
Eriksen J. Infect Dis (Lond). Jan 2020; : 1-35
Pubmed [8244]
Eriksson AS. Epilepsia. Aug 1996; 37(8): 769-73
Pubmed [1045]
Eriksson E. Neuropsychopharmacology. Apr 1995; 12(2): 167-76
Pubmed [12339]
Erjavec et al. J Clin Pharmacol (2000) 40, 1286-1295 [1367]
Erjavec MK. J Clin Pharmacol. Nov 2000; 40(11): 1286-95
Pubmed [7944]
Erken Pamukcu H. Anatol J Cardiol. Oct 2018; 20(4): 213-219
Pubmed , Volltext , DOI [8105]
Erle G. Eur J Clin Pharmacol. Jan 1977; 11(1): 15-8
Pubmed [809]
Ermer J. Clin Drug Investig. Apr 2013; 33(4): 243-54
Pubmed [12515]
Ermer JC. CNS Drugs. Dec 2010; 24(12): 1009-25
Pubmed [8274]
Ernest et al. J Pharmacol Exp Ther. 2005 Feb;312(2):583-91 [3130]
Ernst Mutschler, Arzneimittelwirkungen Pharmakologie-Klinische Pharmakologie- Toxikologie, 11.. [11769]
Ernst Mutschler, Mutschler Arzneimittelwirkungen : Lehrbuch der Pharmakologie, der klinischen Pharmakologie und Toxikologie ; mit einführenden Kapiteln in die Anatomie, Physiologie und Pathophysiologie ; mit 257 Tabellen und 1417 Strukturformeln.: 207-208 [9654]
Ernstgård L. Br J Clin Pharmacol. Aug 2004; 58(2): 190-200
Pubmed , Volltext , DOI [92]
Eron JJ Jr. Lancet HIV. Dec 2018
Pubmed [8523]
Eronen M. Am J Psychiatry. Dec 2003; 160(12): 2242-3
Pubmed [8052]
Erosa SC. Curr Pain Headache Rep. Feb 2021; 25(3): 18
Pubmed [11216]
Errasti P. Transplant Proc. Feb 2002; 34(1): 137-9
Pubmed [4148]
Ersöz G. Turk J Gastroenterol. Oct 2011; 22(5): 494-9
Pubmed [4551]
Eryilmaz G. Int J Psychiatry Clin Pract. Oct 2014; 18(4): 288-92
Pubmed [667]
Erzengin M. Arch Physiol Biochem. Feb 2014; 120(1): 29-33
Pubmed [9699]
Esmaeili-Dooki MR. Iran J Pediatr. Dec 2015; 25(6): e2360
Pubmed , Volltext , DOI [7686]
Espelin DE,Done AK. Amphetamin poisoning: Effectiveness of chlorpromazine. N Engl J Med (1968) 278, 1361-65 [2059]
Espelin DE. N Engl J Med. Jun 1968; 278(25): 1361-5
Pubmed [4875]
Espinosa-Juárez JV. Drug Dev Res. May 2016; 77(3): 134-42
Pubmed [9690]
Esposito C. Biomed Pharmacother. Dec 2021; 144: 112308
Pubmed [11775]
Esposito S. Expert Opin Pharmacother. Jan 2015; 16(15): 2319-30
Pubmed [5201]
Esteban J. Drug Metab Lett. Dec 2008; 2(4): 269-79
Pubmed [7129]
Esteve Pharmaceuticals GmbH, Berlin/Deutschland. . Nov 2021
Pubmed [13235]
Estévez JA. J Antimicrob Chemother. Aug 2012; 67(8): 2013-9
Pubmed [6069]
Estrada DE. Diabetes. Dec 1996; 45(12): 1798-804
Pubmed [11728]
Etchegoyen CV. Curr Clin Pharmacol. Feb 2018
Pubmed [4871]
Etienne Y. J Heart Valve Dis. May 2011; 20(3): 348-50
Pubmed [11010]
Etogo-Asse F. Acta Gastroenterol Belg. Jan 2008; 71(1): 36-8
Pubmed [11402]
Ette EI. J Clin Pharmacol. Oct 1987; 27(10): 813-6
Pubmed [8809]
Eudaley ST. J Pharm Pract. Jul 2022; : 8971900221116009
Pubmed [12939]
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. J Hepatol. Aug 2017; 67(2): 370-398
Pubmed [7930]
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. J Hepatol. Aug 2018; 69(2): 461-511
Pubmed [7936]
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. J Hepatol. Jan 2017; 66(1): 153-194
Pubmed [7929]
Euwema MS. . Mar 2021
Pubmed [10783]
Evanger N. Can J Hosp Pharm. Nov 2017; 70(6): 463-467
Pubmed , Volltext [4957]
Evans DC. Drug Metab Dispos. Jul 2003; 31(7): 861-9
Pubmed [4640]
Evans JL. Diabetes Technol Ther. Oct 2000; 2(3): 401-13
Pubmed [11729]
Evans RL. J Clin Psychopharmacol. Oct 1990; 10(5): 355-9
Pubmed [485]
Evans RW. Headache. Jun 2010; 50(6): 1089-99
Pubmed [992]
Evans SG. Trans R Soc Trop Med Hyg. Nov 1994; 88(6): 683-6
Pubmed [8722]
Evans-Prosser CD. Br J Anaesth. Apr 1968; 40(4): 279-82
Pubmed [13116]
Evers S. Eur J Neurol. Jun 2006; 13(6): 560-72
Pubmed [8475]
Evidente VG. Parkinsonism Relat Disord. Dec 2003; 10(2): 117-21
Pubmed [10437]
Evins AE. J Clin Psychopharmacol. Aug 2007; 27(4): 380-6
Pubmed [10303]
Exeltis Deutschland GmbH, Ismaning/Deutschland, Fachinformation zu XONVEA TM 10 mg/10 mg magensaftresistente Tabletten.Feb 2022 [13475]
Eyer F. Alcohol Alcohol. Mar 2011; 46(2): 177-84
Pubmed [1013]
Eyer F. J Clin Psychopharmacol. Jun 2006; 26(3): 325-30
Pubmed [9776]
Ezuruike U. Clin Pharmacol Ther. Dec 2018; 104(6): 1229-1239
Pubmed , Volltext , DOI [8229]
Faaij RA. J Nutr Health Aging. Mar 2009; 13(3): 275-6
Pubmed [1687]
Fabbiani M. Pharmacol Res. Mar 2011; 63(3): 249-53
Pubmed [7359]
Fabbri M. Drugs Aging. Dec 2018; 35(12): 1041-1054
Pubmed [12211]
Fabbri M. Mov Disord. Oct 2018; 33(10): 1528-1539
Pubmed [12196]
Fabbri M. Neurodegener Dis Manag. Oct 2016; 6(5): 349-62
Pubmed [12202]
Faber MS. Basic Clin Pharmacol Toxicol. Sep 2005; 97(3): 125-34
Pubmed [3167]
Faber MS. Clin Pharmacol Ther. Aug 2004; 76(2): 178-84
Pubmed [429]
Facciolá G. Eur J Clin Pharmacol. Mar 2001; 56(12): 881-8
Pubmed [13993]
Facciolà G. Ther Drug Monit. Jun 1999; 21(3): 341-5
Pubmed [1210]
Fachi MM. Br J Clin Pharmacol. Oct 2019; 85(10): 2280-2291
Pubmed [11214]
Fachinfo Dezember 1999 [2047]
Fachinfo EMB-Fatol® [3429]
Fachinfo Noxafil (Posaconazol) [4112]
Fachinfo Phenytoin AWD 01/2009, bei Abfassung jüngste Fachinfo zu Phenytoin [2135]
Fachinfo Prezista® [3426]
Fachinfomation Norvasc®, Stand der Information, Oktober 2011 [3472]
Fachinforamtion Tranylcypromin 2007 [2354]
Fachinformaation Oxygesic®, Stand März 2010 [174]
Fachinformatin Sifrol April 2009 [2898]
Fachinformation (Glivec), Oktober 2002 [2177]
Fachinformation 04/2001 [1415]
Fachinformation 04/2002 [2123]
Fachinformation 05/2002 [2490]
Fachinformation 06/2002 [1117]
Fachinformation 08/2008 [1445]
Fachinformation 2000 [1829]
Fachinformation 2002 [570]
Fachinformation 2007 [2627]
Fachinformation Abilify [582]
Bildrechte: © spinetta / Fotolia